Introduction
============

Hemodynamic management in high-risk surgery patients is a challenge for anesthesiologists. Clinical variables such as arterial blood pressure (BP), heart rate (HR), and urine output (UO) do not detect tissue hypoperfusion during the early stage of surgery. Furthermore, static parameters such as central venous pressure (CVP) and pulmonary capillary wedge pressure (PCWP) reportedly provide little information regarding preload or fluid responsiveness \[[@B1],[@B2]\]. Fluid management focusing on these parameters may under- or over-hydrate patients, which can increase postoperative morbidity \[[@B3]\]. Initially, the goal of hemodynamic intervention was to maintain supra-normal oxygen delivery (DO~2~) by maintaining a certain level of flow-related hemodynamic variables, including cardiac output (CO) by administering fluid, drugs, or blood products. Following a historical report showing that an increase in CO measured using a pulmonary artery catheter (PAC) improved postoperative outcomes \[[@B4]\], several studies have demonstrated the benefits of a hemodynamic optimization protocol \[[@B5]-[@B7]\].

Previously, the hemodynamic management of CO or DO~2~ required invasive techniques such as a PAC; however, technological advances have made minimally or noninvasive CO monitoring techniques readily available \[[@B8]-[@B10]\] for clinicians to use goal-directed hemodynamic management in high-risk surgery patients. The findings of recent meta-analyses confirmed that preemptive hemodynamic intervention or the maintenance of tissue perfusion decreased postoperative mortality, morbidity, and organ failure \[[@B11],[@B12]\]. Furthermore, dynamic parameters of fluid responsiveness such as stroke volume variation (SVV), pulse pressure variation (PPV), and the pleth variability index (PVI) can reveal variations in stroke volume induced by cardiopulmonary interactions during mechanical ventilation and identify patients who need fluid administration to increase their CO \[[@B13]-[@B15]\]. Thus, minimally invasive CO monitors and surrogates for predicting fluid responsiveness are available for anesthesiologists as routine hemodynamic monitors to optimize the hemodynamic status of high-risk surgery patients. However, a previous survey of American and European anesthesiologists showed that a considerable gap exists between the perceived benefits of hemodynamic optimization and clinical implementation of the available technology \[[@B16]\].

The present survey aimed to assess current hemodynamic monitoring and management of high-risk surgery patients among South Korean anesthesiologists.

Materials and Methods
=====================

Our Institutional Review Board approved the survey. The target population was board-certified members of the Korean Society of Anesthesiologists (KSA). The KSA office e-mail database includes the e-mail addresses of 3,943 board-certified anesthesiologists registered with the organization, but about 1,000 addresses are invalid. After excluding invalid addresses, the remainder includes members who no longer practice anesthesia (e.g., pain clinicians, honorary members, and retired members). All e-mails were sent by the KSA and no e-mail addresses were provided to the authors. Two methods were used to distribute the survey to maximize the response rate and participation. The initial invitation to participate appeared in the KSA e-newsletter. One week later, an e-mail inviting participation was sent to each of the 3,943 members of the KSA. Finally, a follow-up e-mail was sent to respondents and non-respondents 6 weeks after the first e-mail; thus, a total of three e-mail invitations to join the study were issued.

The invitation cover letter included the purpose of the survey, the name and affiliation of the researcher, and the potential benefit of the survey. The cover letter encouraged respondents to participate, and a link to the survey web page was shown at the end of the letter ([www.surveymonkey.com](http://www.surveymonkey.com)). The survey was open for 3 months, from December 30, 2011 to March 31, 2012.

Survey description
------------------

We adopted the definition of a high-risk surgery patient used in previous studies for noncardiac surgery \[[@B16],[@B17]\]. The criteria included patients aged 18 years or older presenting for major surgery with an expected duration of more than 1.5 h and having at least two of the following:

Cardiac or respiratory illness resulting in functional limitationsExtensive surgery planned for carcinoma involving bowel anastomosisPredictable acute massive blood loss (\> 2.5 L)Aged \> 70 years with a functional limitation in one or more organ systemsSepticemia (positive blood culture or septic focus)Respiratory failure (PaO~2~ \< 60 mmHg on FiO~2~ \> 0.4; that is, a PaO~2~:FiO~2~ ratio of \< 150 mmHg or ventilation \> 48 h)Acute abdominal catastrophe (e.g., pancreatitis, perforated viscous, or gastro-intestinal bleed)Acute renal failure (urea \> 20 mmol/L and creatinine \> 260 µmol/L)Surgery for abdominal aortic aneurysmDisseminated malignancy

The survey contained 33 questions divided into two parts consisting of respondent demographic data (14 questions) and clinical experience in the anesthetic management of high-risk surgical patients (19 questions). The questionnaire was identical to that published in 2011 with the exception that the present survey asked for the city in which the respondent practiced \[[@B16]\]. The full questionnaire used in this survey is shown in the [Appendix](#APP1){ref-type="app"}.

Questions regarding the current practice of hemodynamic monitoring in high-risk surgery patients
------------------------------------------------------------------------------------------------

### Routine hemodynamic monitoring and hemodynamic optimization

Questions were asked concerning the respondent\'s routine hemodynamic monitoring practice and the intraoperative frequency with which they optimized parameters of hemodynamic monitoring such as invasive arterial pressure (IAP), CVP, CO, mixed venous oxygen saturation (Svo~2~), central venous oxygen saturation (Scvo~2~), and dynamic parameters of fluid responsiveness such as PPV, systolic pressure variation (SPV), and plethysmographic waveform variation. The respondents were asked which methods they used to evaluate the dynamic parameters of fluid responsiveness, and at what point during surgery optimization procedures were performed.

### CO monitoring

Respondents were asked what technique they currently used to monitor CO, and if they did not routinely monitor CO, they were asked to indicate why.

### Volume management

Four questions on volume management included diagnostic indicators of volume expansion, an assessment of the hemodynamic effect of volume expansion, the best predictor of volume expansion, and the type of fluid used for volume expansion.

### Other questions

We asked the respondents whether they believed oxygen delivery to tissues was of major importance and whether they felt their current hemodynamic management approach could be improved.

Statistics
----------

Respondents who did not perform or directly supervise anesthesia for high-risk patients were excluded from the analysis. The data are expressed as the number of respondents and percentages. Results from a previously published survey conducted among American Society of Anesthesiology (ASA) and European Society of Anesthesiology (ESA) members were included for comparison \[[@B16]\]. All statistical tests were conducted using the Statistical Package for the Social Sciences version 14.0 (SPSS Inc., Chicago, IL, USA).

Results
=======

We received 139 responses from KSA members. Of those, 22 indicated that they did not administer or supervise anesthesia for high-risk patients. Among the remaining 117 respondents, 6 did not answer any further questions and were excluded from the analysis. The remaining 111 respondents were included in the analysis, and, of those, 70 (63%) completed the entire questionnaire.

Demographic data
----------------

Most of the respondents worked at university (79%) or general (19%) hospitals. In a typical work week, they reported administering or directly supervising anesthesia for high-risk patients 1-5 times (61%), 6-10 times (19%), or \> 11 times (10%). More than half reported that they administered anesthesia for various types of surgery. We found that 13% of the respondents were cardiac anesthesiologists and 9% were transplant anesthesiologists.

Furthermore, 30% of the respondents worked at a hospital with more than 1,000 beds, 60% worked at hospitals with 500-1,000 beds, 59% worked in hospitals with \> 40 intensive care unit beds, 50% of respondents finished training after the year 2000, and 60% of the respondents completed fellowship training. The most frequent fellowship was cardiac anesthesia (33%) followed by critical care, pain, research, and transplant anesthesia. About 70% of respondents practiced in Seoul, Gyeonggi, and Busan.

Questions regarding the current practice of hemodynamic monitoring in high-risk surgery patients
------------------------------------------------------------------------------------------------

Two-thirds (66%) of 109 respondents reported that their institution or group did not have a written protocol, care guide, or statement concerning hemodynamic management in high-risk surgery patients; 10% answered that they were unsure or did not know, whereas 24% reported that a protocol was in place ([Fig. 1](#F1){ref-type="fig"}).

Routine hemodynamic monitoring and hemodynamic optimization
-----------------------------------------------------------

The most commonly reported methods for routine hemodynamic monitoring were IAP (97%) and CVP (93%), followed by CO (59%) and SVV (51%) ([Table 1](#T1){ref-type="table"}).

The frequency of intraoperative hemodynamic optimization for \> 50% of the time for each parameter was highest for BP followed by CVP and CO ([Fig. 2](#F2){ref-type="fig"}). In contrast, no respondent reported optimizing Scvo~2~ or Svo~2~ \> 50% of the time. Approximately 60% of the respondents reported that they optimized hemodynamics during surgery and after the induction of anesthesia. Half of the respondents regarded the intraoperative period as the most critical time for hemodynamic optimization.

CO monitoring
-------------

The most frequently used CO monitoring device was the Flotrac/Vigileo monitor (79%) followed by the Swan Ganz catheter (52%), transesophageal echocardiography (TEE, 32%), and esophageal Doppler (13%) ([Fig. 3](#F3){ref-type="fig"}). The two main reasons for not monitoring CO in high-risk surgery patients were a preference for measuring dynamic parameters rather than the direct measurement of CO (37%) and the invasiveness of current CO monitoring techniques (32%). Moreover, 19% of the respondents felt that CO monitoring did not provide additional clinically relevant information ([Table 2](#T2){ref-type="table"}). However, 94% of the respondents indicated that oxygen delivery to tissues was of major importance during high-risk surgery.

Volume management
-----------------

More than 80% of the respondents replied that BP (85%) and UO (81%) were diagnostic indicators of volume expansion, followed by CVP (73%), clinical experience (71%), and CO (57%). Dynamic parameters were regarded as better indicators than TEE and PCWP (51%) ([Table 3](#T3){ref-type="table"}). The respondents used primarily classic parameters such as increased BP and UO, decreased HR, and clinical experience to assess the hemodynamic effect of volume expansion. Half of the respondents routinely measured CO to assess the effects of volume expansion, and SVV was used more frequently than PPV or SPV among the dynamic parameters ([Table 4](#T4){ref-type="table"}). More respondents felt that SVV (20%) or CO (17%) was a better predictor of volume expansion than BP (9%) or CVP (3%) ([Table 5](#T5){ref-type="table"}).

The dynamic parameters of fluid responsiveness were measured by eyeballing (44%), automatic measurement using specific software (41%), and manual calculations (16%).

The most commonly used fluid for volume expansion was hydroxyethyl starch (73%), followed by crystalloid (18%) and blood products (7%).

Finally, 88% of the respondents believed that their current hemodynamic management approach could be improved.

Discussion
==========

The results of our survey indicate that significant numbers of KSA respondents routinely monitor CO in high-risk surgery patients. However, CO was consistently optimized by \< 20% of anesthesiologists, demonstrating a gap between the monitoring and optimization of CO in high-risk surgery patients. Furthermore, the respondents considered BP, CVP, HR, UO, and clinical experience to be better indicators or surrogates of volume expansion than CO or dynamic parameters of fluid responsiveness. The present results indicate that CO optimization is not widely used by Korean anesthesiologists, despite substantial evidence showing that CO optimization improves postoperative outcomes in high-risk surgery patients \[[@B11],[@B12]\].

The present survey was conducted to assess current hemodynamic monitoring practices, particularly CO monitoring and optimization, in high-risk surgery patients in South Korea. Besides IAP, CVP, and non-invasive BP, we found that more than half of the KSA respondents routinely monitored CO (59%) and SVV (51%). The monitoring frequencies of CO and SVV in our survey were higher than those reported in a survey by the ASA and ESA, in which routine CO monitoring was done by 35% of ASA and ESA respondents, and SVV was routinely monitored by 6% of ASA and 22% of ESA respondents \[[@B16]\]. This unexpectedly high frequency of CO and SVV monitoring may be attributable to the high rate (79%) of Flotrac/Vigileo monitor use. We speculate that the minimal invasiveness of the system, which uses an existing arterial catheter and simultaneously monitors SVV, may have contributed to the high frequency of CO monitoring in high-risk surgery patients.

Our results show that more respondents optimized BP than CO or dynamic parameters. Despite the relatively high frequency of monitoring CO, few respondents in the present study reported optimizing CO for \> 50% of the intraoperative time, revealing a discrepancy between CO monitoring and optimization. This discrepancy is consistent with the survey findings of the ASA and ESA \[[@B16]\]. While evidence indicates that CO optimization or maximization improves the outcome of high-risk surgery patients in terms of postoperative complications, mortality, and hospital stay \[[@B18]-[@B20]\], our survey demonstrated that many anesthesiologists in Korea do not use a routine CO optimization strategy in their clinical practice. This is an opportunity for improvement. As stated by Dr. Michael Pinsky, \"No monitoring tool, no matter how accurate, by itself has improved patient outcome\" \[[@B21]\], suggesting that only the actual practice of CO optimization has the potential to improve outcome. Several explanations for this gap are as follows. First, the benefits of CO optimization are not universally accepted; some believe that CO maximization is unnecessary or may be harmful \[[@B22],[@B23]\]. Second, because the benefits of hemodynamic optimization appear post-surgery (e.g., reductions in morbidity or the length of hospitalization), anesthesiologists, particularly those not involved in postoperative care, may not be aware of or concerned about patient outcomes during the intraoperative period \[[@B24]\]. Third, flow-based, protocol-oriented fluid management is labor-intensive and requires the frequent assessment of fluid responsiveness after each administration. The procedure is difficult to perform routinely in the busy operating room environment. Finally, the absence of guidelines or a protocol may contribute to an anesthesiologist\'s reluctance to adopt this approach. The development of a protocol and quality assurance process to improve postoperative outcomes may be helpful in resolving these uncertainties \[[@B25]\].

Identifying responders and non-responders to fluid administration is important to guide fluid therapy in high-risk surgery patients. Dynamic indices are now well accepted to be better predictors of fluid responsiveness than static indices in patients with mechanical ventilation \[[@B26]\]. The respondents in the current survey also recognized dynamic indices such as SVV as the best predictors of fluid responsiveness; only 3% believed that CVP is an accurate predictor. This observation is of major significance for at least two reasons. First, while Korean anesthesiologists understand that CVP is a weak predictor of fluid responsiveness, 93% still monitor this variable during high-risk surgery, which is at least 20% higher than what had been reported by ASA and ESA members. Second, Korean anesthesiologists merely monitor CVP rather than try to optimize it, which raises the question of why CVP is still monitored in this setting. Recent quality improvement programs implementing CO optimization during major surgery have shown that this approach decreases the use of central venous catheters, which may, in turn, decrease the incidence of central line-related complications \[[@B9]\]. The results of our study indicate that many anesthesiologists in Korea still rely heavily on CVP in fluid management despite their recognition that dynamic parameters are better predictors of fluid responsiveness. Familiarity with traditional variables and a lack of implementation of formal protocols for CO optimization may be the reason for this result. This needs to be re-evaluated if the unusually high use of CVP monitoring has any advantage for hemodynamic monitoring during high-risk surgery in Korea.

Study limitations
-----------------

The low response rate (4%) to our survey, causing a high likelihood of non-responder bias, was largely due to the limitations of our survey method. We believe that the inclusion of a large number of incorrect e-mail addresses was the primary reason for the low response rate. Thus, it was difficult to estimate the denominator population, making it almost impossible to correctly estimate the response rate. This is a common weakness of e-mail- and web-based surveys \[[@B27]\]. Moreover, the majority of respondents practiced at university or general hospitals where many high-risk surgeries are performed, suggesting that the survey was not of interest to all KSA members. A topic that was of interest to only one faction of the target population is likely to have contributed to the low response rate \[[@B28]\]. As a result of these limitations, our survey respondents are not representative of the entire KSA membership; thus, careful consideration is needed when generalizing our findings.

In conclusion, the present study shows that despite a relatively high frequency of CO monitoring, many Korean anesthesiologists do not frequently optimize it in high-risk surgery patients.

The authors thank the KSA for advertising our survey and sending e-mails to its members. We particularly thank the anesthesiologists who participated in this survey.

Korean Society of Anesthesiology Hemodynamic Monitoring Questionnaire
=====================================================================

![Does your institution or group have a written protocol, care guide, or statement concerning hemodynamic management in this setting?](kjae-65-19-g001){#F1}

![How frequently do you try to optimize arterial pressure, central venous pressure, and cardiac output in this setting?](kjae-65-19-g002){#F2}

![What technique do you use to monitor cardiac output?](kjae-65-19-g003){#F3}

###### 

What Hemodynamic Monitoring Do You Routinely Use for the Management of High-risk Surgery Patients? (Please, Mark All That Apply)

![](kjae-65-19-i001)

KSA: Korean Society of Anesthesiologists, ASA: American Society of Anesthesiology respondents, ESA: European Society of Anaesthesiology respondents. We obtained permission by the publisher to use data from ASA and ESA.

###### 

If You Do Not Monitor Cardiac Output Routinely in These Patients, What Are the Main Reasons for not Monitoring It? (Please, Mark All That Apply)

![](kjae-65-19-i002)

KSA: Korean Society of Anesthesiologists, ASA: American Society of Anesthesiology respondents, ESA: European Society of Anaesthesiology respondents. We obtained permission by the publisher to use data from ASA and ESA.

###### 

What Are Your Indicators for Volume Expansion in This Setting (Diagnostic Tools)? (Please, Mark All That Apply)

![](kjae-65-19-i003)

KSA: Korean Society of Anesthesiologists, ASA: American Society of Anesthesiology respondents, ESA: European Society of Anaesthesiology respondents. We obtained permission by the publisher to use data from ASA and ESA.

###### 

How Do You Routinely Assess the Hemodynamic Effects of Volume Expansion in This Setting?

![](kjae-65-19-i004)

KSA: Korean Society of Anesthesiologists, ASA: American Society of Anesthesiology respondents, ESA: European Society of Anaesthesiology respondents. We obtained permission by the publisher to use data from ASA and ESA.

###### 

In Your Opinion, What Best Predicts an Increase in Cardiac Output Following Volume Expansion?

![](kjae-65-19-i005)

KSA: Korean Society of Anesthesiologists, ASA: American Society of Anesthesiology respondents, ESA: European Society of Anesthesiology respondents. We obtained permission by the publisher to use data from ASA and ESA.
